All > Her 2 Positive Breast Cancer > Oncology

Contrast-enhanced mammogram for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Magee Womancare Passavant Cranberry, Cranberry Township, PABreast Cancer+3 MoreContrast-enhanced mammogram - Device
Eligibility
30 - 85
Female
What conditions do you have?
Select

Study Summary

This trial will compare cancer detection rates of two types of mammograms, one with and one without contrast enhancement.

Eligible Conditions
  • Breast Cancer
  • Tumors

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Contrast-enhanced digital breast tomosynthesis (CE-DBT)
1
Contrast-Enhanced Ultrasound
2
Laboratory Biomarker Analysis

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 48 months

48 months
Cancer Detection
Reader Validation

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Contrast-enhanced digital breast tomosynthesis (CE-DBT)
2
Contrast-Enhanced Ultrasound
3
Laboratory Biomarker Analysis

Trial Design

1 Treatment Group

Contrast-enhanced mammogram
1 of 1

Experimental Treatment

1650 Total Participants · 1 Treatment Group

Primary Treatment: Contrast-enhanced mammogram · No Placebo Group · N/A

Contrast-enhanced mammogram
Device
Experimental Group · 1 Intervention: Contrast-enhanced mammogram · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 48 months

Who is running the clinical trial?

Wendie BergLead Sponsor
2 Previous Clinical Trials
6,866 Total Patients Enrolled
2 Trials studying Breast Cancer
6,866 Patients Enrolled for Breast Cancer
Breast Cancer Research FoundationOTHER
61 Previous Clinical Trials
133,877 Total Patients Enrolled
36 Trials studying Breast Cancer
126,938 Patients Enrolled for Breast Cancer
Wendie Berg, MD, PhD5.01 ReviewsPrincipal Investigator - University of Pittsburgh
University of Pittsburgh
2 Previous Clinical Trials
6,866 Total Patients Enrolled
2 Trials studying Breast Cancer
6,866 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 30 - 85 · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the estimated enrollment rate for this experiment?

"Affirmative. According to the info on clinicaltrials.gov, this study is still seeking participants which it initially posted for in October 2019 and more recently updated in September 2022. The trial requires 1650 people from 3 different locations to take part." - Anonymous Online Contributor

Unverified Answer

May I qualify to take part in this medical trial?

"In order to be eligible, individuals must have a diagnosis of breast cancer and be aged between 30 and 85. This trial aims to recruit approximately 1650 participants." - Anonymous Online Contributor

Unverified Answer

Are there any opportunities still available for participation in this experiment?

"That is correct. Clinicaltrials.gov attests that this investigation, which was first advertised on October 23rd 2019, is actively recruiting participants. 1,650 individuals are needed from three distinct clinical locations to take part in the trial." - Anonymous Online Contributor

Unverified Answer

Does this research endeavor offer opportunities for individuals aged 45 and above?

"This particular clinical research effort is searching for participants between the ages of 30 and 85. Those younger than that age threshold can look to 370 alternative trials, while those older have access to 4,568 studies." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top